0.7729
price down icon4.32%   -0.0371
 
loading

Glucotrack Inc (GCTK) 最新ニュース

pulisher
04:36 AM

Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor - MSN

04:36 AM
pulisher
Feb 04, 2025

Glucotrack reports success in first human glucose monitor trial By Investing.com - Investing.com Canada

Feb 04, 2025
pulisher
Feb 04, 2025

GCTKGlucoTrack, Inc. Latest Stock News & Market Updates - StockTitan

Feb 04, 2025
pulisher
Feb 04, 2025

Market cap of GlucoTrack Inc [GCTK] reaches 8.86M – now what? - The DBT News

Feb 04, 2025
pulisher
Feb 04, 2025

Glucotrack, Inc. Announces Pricing Of $3.0 Million Public Offering -February 04, 2025 at 01:59 pm EST - Marketscreener.com

Feb 04, 2025
pulisher
Feb 04, 2025

Glucotrack hits trial success for direct blood measuring CGM - Yahoo! Voices

Feb 04, 2025
pulisher
Feb 04, 2025

Glucotrack sets terms for $3 million public stock offering - Investing.com

Feb 04, 2025
pulisher
Feb 04, 2025

GlucoTrack Prices $3 Million Public Offering; Shares Fall -February 04, 2025 at 12:48 pm EST - Marketscreener.com

Feb 04, 2025
pulisher
Feb 04, 2025

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering - The Manila Times

Feb 04, 2025
pulisher
Feb 04, 2025

Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle – market - HPBL

Feb 04, 2025
pulisher
Feb 04, 2025

Diabetes Tech Pioneer Glucotrack Raises Fresh Capital: Key Details of $3M Share Offering Revealed - StockTitan

Feb 04, 2025
pulisher
Feb 04, 2025

Glucotrack completes first-in-human continuous blood glucose monitor implant study - Mass Device

Feb 04, 2025
pulisher
Feb 04, 2025

Glucotrack stock soars on completion of first human clinical study of CBGM - Seeking Alpha

Feb 04, 2025
pulisher
Feb 04, 2025

GlucoTrack Announces Reverse Stock Split and Clinical Study Success - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

Glucotrack completes first-in-human CGM implant study - Drug Delivery Business News

Feb 04, 2025
pulisher
Feb 04, 2025

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor - The Manila Times

Feb 04, 2025
pulisher
Feb 04, 2025

Glucotrack reports success in first human glucose monitor trial - Investing.com

Feb 04, 2025
pulisher
Feb 04, 2025

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous - The Bakersfield Californian

Feb 04, 2025
pulisher
Feb 04, 2025

Revolutionary Blood Glucose Monitor Shows Promise: Direct Blood Measurement Could Transform Diabetes Care - StockTitan

Feb 04, 2025
pulisher
Feb 03, 2025

GlucoTrack Inc: -98.71% Growth from 52-Week Low, Yet Analysts Divided - The InvestChronicle

Feb 03, 2025
pulisher
Feb 01, 2025

Glucotrack, Inc. Announces 1-for-20 Reverse Stock Split - Defense World

Feb 01, 2025
pulisher
Jan 31, 2025

GCTK Stock Plummets to 52-Week Low of $0.06 Amid Market Turbulence - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

GlucoTrack Announces Resignation of Chief Financial Officer and Appointment of Peter Wulff as Replacement**WASHINGTON, D.C. 2025 – GlucoTrack, Inc. (NASDAQ: GCTK) recently disclosed on January 27, 2025, that James Cardwell, the Chief Financial - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

Glucotrack announces 1-for-20 reverse stock split - Investing.com India

Jan 30, 2025
pulisher
Jan 30, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jan 30, 2025
pulisher
Jan 30, 2025

GlucoTrack Announces 1-for-20 Reverse Stock Split - TipRanks

Jan 30, 2025
pulisher
Jan 30, 2025

Glucotrack to execute 1-for-20 reverse stock split - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

GlucoTrack, Inc. Announces Chief Financial Officer Changes -January 29, 2025 at 09:00 am EST - Marketscreener.com

Jan 30, 2025
pulisher
Jan 30, 2025

Glucotrack announces 1-for-20 reverse stock split By Investing.com - Investing.com Canada

Jan 30, 2025
pulisher
Jan 30, 2025

Glucotrack's Strategic Move: 1-for-20 Reverse Split Could Save Nasdaq Listing - StockTitan

Jan 30, 2025
pulisher
Jan 29, 2025

Glucotrack Appoints Peter C. Wulff as CFO - citybiz

Jan 29, 2025
pulisher
Jan 29, 2025

GlucoTrack Appoints Peter Wulff as CFO -January 29, 2025 at 11:41 am EST - Marketscreener.com

Jan 29, 2025
pulisher
Jan 29, 2025

GlucoTrack Strengthens Leadership with New CFO Appointment - TipRanks

Jan 29, 2025
pulisher
Jan 29, 2025

35-Year MedTech Finance Veteran Joins Glucose Monitor Innovator as New CFO - StockTitan

Jan 29, 2025
pulisher
Jan 22, 2025

How Is The Market Feeling About GlucoTrack? - Benzinga

Jan 22, 2025
pulisher
Jan 22, 2025

Headwater Exploration (OTCMKTS:CDDRF) Trading 3.1% Higher – Should You Buy? - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

Cuisine Solutions (OTCMKTS:CUSI) Shares Down 0.5% – Here’s Why - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

StockNews.com Upgrades Park Aerospace (NYSE:PKE) to Buy - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

Interfor (TSE:IFP) Given New C$26.00 Price Target at Raymond James - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

Li Ning (OTCMKTS:LNNGF) Trading 3.3% Higher – Here’s What Happened - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

John Bean Technologies (NYSE:JBT) Now Covered by StockNews.com - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

Old Second Bancorp Declares Quarterly Cash Dividend On January 21, 2025, Old Second Bancorp, Inc. (NASDAQ: OSBC) announced through a Form 8-K filing that its Board of Directors has approved a cash dividend of $0.06 per share. The dividend is set to - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

Jupiter Wellness (NASDAQ:JUPW) Reports Regulation FD Disclosure Concerning Safety Shot, Inc. - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

Ark Restaurants (NASDAQ:ARKR) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

NextSource Materials (OTCMKTS:NSRCF) Stock Price Up 7.1% – Time to Buy? - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

FIBRA Terrafina (OTCMKTS:CBAOF) Trading 13% Higher – Should You Buy? - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

Tabcorp (OTCMKTS:TACBY) Shares Down 12% – Here’s What Happened - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

Telefónica (OTCMKTS:TEFOF) Trading Down 7.3% – What’s Next? - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

BEO Bancorp (OTCMKTS:BEOB) Stock Price Down 1.2% – Here’s What Happened - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

Vicarious Surgical Inc. Enters into Consulting Agreement with Former CFOWASHINGTON, D.C. 20549 — On January 17, 2025, Vicarious Surgical Inc. (NYSE: RBOT) filed a current report on Form 8-K with the Securities and Exchange Commission, detailing th - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Jan 21, 2025
pulisher
Jan 21, 2025

GlucoTrack Achieves ISO13485:2016 Certification for CBGM - TipRanks

Jan 21, 2025
pulisher
Jan 21, 2025

Glucotrack Announces ISO 13485:2016 Certification - The Manila Times

Jan 21, 2025
pulisher
Jan 21, 2025

Glucotrack Achieves Critical ISO 13485 Certification for Glucose Monitoring Technology - StockTitan

Jan 21, 2025
pulisher
Jan 18, 2025

US Equities Close Mixed as Tech Gains Offset Weakness in Defensive Sectors – Market - HPBL

Jan 18, 2025
pulisher
Jan 17, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jan 17, 2025
$22.26
price up icon 0.70%
$216.90
price up icon 1.00%
medical_instruments_supplies BAX
$31.51
price up icon 0.51%
$71.98
price up icon 0.56%
medical_instruments_supplies COO
$95.84
price up icon 0.47%
medical_instruments_supplies WST
$327.74
price up icon 0.01%
大文字化:     |  ボリューム (24 時間):